Actavis plc (NYSE ACT) is a global integrated specialty pharmaceutical company focused on developing manufacturing and distributing generic brand and biosimilar products.
Red biotechnology refers to pharmaceutical, medicinal and diagnostic applications of biotechnology. Typical red biotech company products include vaccines, therapeutics, diagnosis kit, cell therapy, and the like. Red biotechnology stakeholders are playing a vital role in increasing the quality and length of human health. Encoded by BioDirecta Database as RED.